SciVision Biotech Inc. (TPE:1786)
Taiwan · Delayed Price · Currency is TWD 109.00
-0.50 (-0.46%)
Oct 9, 2025, 1:30 PM CST
SciVision Biotech Revenue
SciVision Biotech had revenue of 209.49M TWD in the quarter ending June 30, 2025, a decrease of -0.51%. This brings the company's revenue in the last twelve months to 891.22M, up 9.32% year-over-year. In the year 2024, SciVision Biotech had annual revenue of 883.31M with 23.89% growth.
Revenue (ttm)
891.22M
Revenue Growth
+9.32%
P/S Ratio
8.83
Revenue / Employee
n/a
Employees
n/a
Market Cap
7.87B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 883.31M | 170.32M | 23.89% |
| Dec 31, 2023 | 712.99M | 155.64M | 27.93% |
| Dec 31, 2022 | 557.35M | 51.81M | 10.25% |
| Dec 31, 2021 | 505.54M | 38.66M | 8.28% |
| Dec 31, 2020 | 466.88M | 29.01M | 6.62% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Caliway Biopharmaceuticals | 44.83M |
| PharmaEssentia | 12.63B |
| Bora Pharmaceuticals Co., LTD. | 21.32B |
| Lotus Pharmaceutical | 19.12B |
| Lumosa Therapeutics | 37.25M |
| Oneness Biotech | 112.57M |
| Polaris Group | 64.02M |
| Center Laboratories | 1.60B |